BUSINESSEURACTIV
Will Swiss pharma be next?
Trump is pressuring Swiss pharmaceutical companies to increase drug prices in Europe. The article questions whether Swiss pharma will face similar pressures as other industries.
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- FIRST AID: German pharma joins Trump pricing fight
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- STAT+: A political contest in the U.K. could shake up drug pricing
- EU drug pricing: Belgium backs coordination push as Greece urges biotech scale-up [Advocacy Lab]